P48356 (LEPR_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 132.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Leptin receptor Short name=LEP-R Alternative name(s): B219 OB receptor Short name=OB-R CD_antigen=CD295 | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 1162 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor for obesity factor (leptin). On ligand binding, mediates signaling through JAK2/STAT3. Involved in the regulation of fat metabolism and, in a hematopoietic pathway, required for normal lymphopoiesis. May play a role in reproduction. Can also mediate the ERK/FOS signaling pathway. Isoform A may act to transport leptin to the cerebrospinal fluid By similarity. Isoform E could function as a transport protein. |
| Subunit structure | On leptin stimulation, homodimerizes. The phosphorylated receptor binds a number of SH2 domain-containing proteins such as STAT3, PTPN11, and SOCS3. Interaction with SOCS3 inhibits JAK/STAT signaling. |
| Subcellular location | |
| Tissue specificity | Isoform A: highest level of expression in lung and kidney, also present in kidney, heart, brain, spleen, liver, muscle, choroid plexus and hypothalamus. Isoform B: highest level of expression in hypothalamus and lower level in brain, testes and adipose tissue. Isoform E: expressed in adipose tissue, hypothalamus, heart, and testes. |
| Domain | The WSXWS motif appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding. Ref.13 The box 1 motif is required for JAK interaction and/or activation. Ref.13 |
| Post-translational modification | On ligand binding, phosphorylated on two conserved C-terminal tyrosine residues (isoform B only) by JAK2. Tyr-985 is required for complete binding and activation of PTPN11, ERK/FOS activation and, for interaction with SOCS3. Phosphorylation on Tyr-1138 is required for STAT3 binding/activation. Ref.10 Ref.11 Phosphorylation of Tyr-985 is required for SOCS3 binding and SOCS3 mediated inhibition of leptin signaling, whereas phosphorylation of Tyr-1077 has a more accessory role. |
| Sequence similarities | Belongs to the type I cytokine receptor family. Type 2 subfamily. Contains 4 fibronectin type-III domains. Contains 1 Ig-like (immunoglobulin-like) domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| BBS1 | Q8NFJ9 | 3 | EBI-6143588,EBI-1805484 | From a different organism. |
Alternative products
| This entry describes 5 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform B (identifier: P48356-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform A (identifier: P48356-2) The sequence of this isoform differs from the canonical sequence as follows: 890-894: PETFE → RTDTL 895-1162: Missing. | ||||||
| Isoform C (identifier: P48356-3) The sequence of this isoform differs from the canonical sequence as follows: 890-892: PET → VTV 893-1162: Missing. | ||||||
| Isoform D (identifier: P48356-4) The sequence of this isoform differs from the canonical sequence as follows: 890-900: PETFEHLFTKH → DISFHEVFIFR 901-1162: Missing. | ||||||
| Isoform E (identifier: P48356-5) The sequence of this isoform differs from the canonical sequence as follows: 797-805: DNFIPIEKY → GMCTVLFMD 806-1162: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 21 | 21 | Potential | ||||||||
| Chain | 22 – 1162 | 1141 | Leptin receptor | PRO_0000010906 | |||||||
Regions | |||||||||||
| Topological domain | 22 – 839 | 818 | Extracellular Potential | ||||||||
| Transmembrane | 840 – 860 | 21 | Helical; Potential | ||||||||
| Topological domain | 861 – 1162 | 302 | Cytoplasmic Potential | ||||||||
| Domain | 236 – 328 | 93 | Fibronectin type-III 1 | ||||||||
| Domain | 329 – 427 | 99 | Ig-like | ||||||||
| Domain | 535 – 629 | 95 | Fibronectin type-III 2 | ||||||||
| Domain | 637 – 729 | 93 | Fibronectin type-III 3 | ||||||||
| Domain | 735 – 827 | 93 | Fibronectin type-III 4 | ||||||||
| Region | 465 – 482 | 18 | Leptin-binding By similarity | ||||||||
| Region | 891 – 896 | 6 | Required for JAK2 activation | ||||||||
| Motif | 620 – 624 | 5 | WSXWS motif | ||||||||
| Motif | 869 – 877 | 9 | Box 1 motif | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 985 | 1 | Phosphotyrosine; by JAK2 Ref.10 | ||||||||
| Modified residue | 1077 | 1 | Phosphotyrosine Ref.10 | ||||||||
| Modified residue | 1138 | 1 | Phosphotyrosine; by JAK2 | ||||||||
| Glycosylation | 41 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 56 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 73 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 98 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 187 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 275 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 345 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 431 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 514 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 622 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 657 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 668 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 686 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 695 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 698 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 726 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 37 ↔ 90 | By similarity | |||||||||
| Disulfide bond | 89 ↔ 99 | By similarity | |||||||||
| Disulfide bond | 131 ↔ 142 | By similarity | |||||||||
| Disulfide bond | 186 ↔ 195 | By similarity | |||||||||
| Disulfide bond | 188 ↔ 193 | By similarity | |||||||||
| Disulfide bond | 350 ↔ 410 | By similarity | |||||||||
| Disulfide bond | 411 ↔ 416 | By similarity | |||||||||
| Disulfide bond | 434 ↔ 445 | By similarity | |||||||||
| Disulfide bond | 471 ↔ 526 | By similarity | |||||||||
| Disulfide bond | 486 ↔ 496 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 797 – 805 | 9 | DNFIPIEKY → GMCTVLFMD in isoform E. | VSP_001703 | |||||||
| Alternative sequence | 806 – 1162 | 357 | Missing in isoform E. | VSP_001704 | |||||||
| Alternative sequence | 890 – 900 | 11 | PETFEHLFTKH → DISFHEVFIFR in isoform D. | VSP_001701 | |||||||
| Alternative sequence | 890 – 894 | 5 | PETFE → RTDTL in isoform A. | VSP_001697 | |||||||
| Alternative sequence | 890 – 892 | 3 | PET → VTV in isoform C. | VSP_001699 | |||||||
| Alternative sequence | 893 – 1162 | 270 | Missing in isoform C. | VSP_001700 | |||||||
| Alternative sequence | 895 – 1162 | 268 | Missing in isoform A. | VSP_001698 | |||||||
| Alternative sequence | 901 – 1162 | 262 | Missing in isoform D. | VSP_001702 | |||||||
| Natural variant | 541 | 1 | V → I in strain: NZO. | ||||||||
| Natural variant | 600 | 1 | D → N in strain: KK Obese. Ref.8 | ||||||||
| Natural variant | 651 | 1 | V → I in strain: NZO. | ||||||||
| Natural variant | 1044 | 1 | T → I in strain: NZO. | ||||||||
Experimental info | |||||||||||
| Mutagenesis | 985 | 1 | Y → L: No change in EPO-induced JAK2 activation and EPO-induced tyrosine phosphorylation. No phosphorylation; when associated with S-1138. No phosphorylation; when associated with both S-1138 and F-1077. No change in STAT3 activation. No PTPN11 binding. No SOCS3 binding nor inhibition of signaling. Greatly reduced ERK/FOS activation. Ref.11 Ref.12 | ||||||||
| Mutagenesis | 1077 | 1 | Y → F: No effect on EPO-induced tyrosine phosphorylation. Ref.11 | ||||||||
| Mutagenesis | 1138 | 1 | Y → S: No change in EPO-induced JAK2 activation and EPO-induced tyrosine phosphorylation. No phosphorylation; when associated with L-985. No phosphorylation; when associated with L-985 and F-1077. No STAT3 activation. No change in SOCS3 binding nor signaling inhibition. No effect on ERK/FOS activation. Ref.11 Ref.12 | ||||||||
| Sequence conflict | 140 | 1 | F → I in AAC52705. Ref.5 | ||||||||
| Sequence conflict | 140 | 1 | F → I in AAC52706. Ref.5 | ||||||||
| Sequence conflict | 140 | 1 | F → I in AAC52707. Ref.5 | ||||||||
| Sequence conflict | 720 | 1 | A → T in CAA71343. Ref.6 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||
References
| [1] | "Identification and expression cloning of a leptin receptor, OB-R." Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G.J., Campfield L.A., Clark F.T., Deeds J., Muir C., Sanker S., Moriarty A., Moore K.J., Smutko J.S., Mays G.G., Woolf E.A., Monroe C.A., Tepper R.I. Cell 83:1263-1271(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A). Tissue: Choroid plexus. |
| [2] | "Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice." Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., Lakey N.D., Culpepper J., Moore K.J., Breitbart R.E., Duyk G.M., Tepper R.I., Morgenstern J.P. Cell 84:491-495(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B). Strain: C57BL/KsJ. Tissue: Hypothalamus. |
| [3] | "Abnormal splicing of the leptin receptor in diabetic mice." Lee G.-H., Proenca R., Montez J.M., Carroll K.M., Darvishzadeh J.G., Lee J.I., Friedman J.M. Nature 379:632-635(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B; C; D AND E). Strain: C57BL/Ks. Tissue: Hypothalamus. |
| [4] | "Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction." Cioffi J.A., Shafer A.W., Zupancic T.J., Smith-Gbur J., Mikhail A., Platika D., Snodgrass H.R. Nat. Med. 2:585-589(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C). Strain: BALB/c. Tissue: Liver. |
| [5] | "Defective STAT signaling by the leptin receptor in diabetic mice." Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M.H., Skoda R.C. Proc. Natl. Acad. Sci. U.S.A. 93:6231-6235(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B). Strain: FVB/N. Tissue: Spleen. |
| [6] | "Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse." Igel M., Becker W., Herberg L., Joost H.G. Endocrinology 138:4234-4239(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B). Strain: NZO. Tissue: Hypothalamus. |
| [7] | "Fine structure of the murine leptin receptor gene: splice site suppression is required to form two alternatively spliced transcripts." Chua S.C., Koutras I.K., Han L., Liu S.M., Kay J., Young S.J., Chung W.K., Leibel R.L. Genomics 45:264-270(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS A; B; C AND E). Strain: 129/J. |
| [8] | "Hyperleptinemia and leptin receptor variant Asp600Asn in the obese, hyperinsulinemic KK mouse strain." Igel M., Taylor B.A., Phillips S.J., Becker W., Herberg L., Joost H.G. J. Endocrinol. 21:337-345(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), VARIANT ASN-600. Strain: KK Obese. Tissue: Hypothalamus. |
| [9] | "Murine leptin receptor genomic exon 18b and surrounding sequence." Banks A.S., Myers M.G. Jr. Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE OF 890-1162 (ISOFORM B). Strain: 129. |
| [10] | "Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor." Eyckerman S., Broekaert D., Verhee A., Vandekerckhove J., Tavernier J. FEBS Lett. 486:33-37(2000) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT TYR-985 AND TYR-1077. |
| [11] | "Activation of downstream signals by the long form of the leptin receptor." Banks A.S., Davis S.M., Bates S.H., Myers M.G. Jr. J. Biol. Chem. 275:14563-14572(2000) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION, STAT3 ACTIVATION, ERK/FOS ACTIVATION, MUTAGENESIS OF TYR-985; TYR-1077 AND TYR-1138. |
| [12] | "SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985." Bjorbaek C., Lavery H.J., Bates S.H., Olson R.K., Davis S.M., Flier J.S., Myers M.G. Jr. J. Biol. Chem. 275:40649-40657(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SOCS3, MUTAGENESIS OF TYR-985 AND TYR-1138. |
| [13] | "Regulation of Jak kinases by intracellular leptin receptor sequences." Kloek C., Haq A.K., Dunn S.L., Lavery H.J., Banks A.S., Myers M.G. Jr. J. Biol. Chem. 277:41547-41555(2002) [PubMed] [Europe PMC] [Abstract] Cited for: DOMAIN JAK2 ACTIVATION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U42467 mRNA. Translation: AAA93014.1. U46135 mRNA. Translation: AAC52408.1. U49106 mRNA. Translation: AAC52420.1. U49107 mRNA. Translation: AAC52421.1. U49108 mRNA. Translation: AAC52422.1. U49109 mRNA. Translation: AAC52423.1. U49110 mRNA. Translation: AAC52424.1. U52915 mRNA. Translation: AAC52599.1. U58861 mRNA. Translation: AAC52705.1. U58862 mRNA. Translation: AAC52706.1. U58863 mRNA. Translation: AAC52707.1. Y10298 mRNA. Translation: CAA71343.1. AF039456 AF039455 Genomic DNA. Translation: AAB95334.1.AF039461 AF039459 Genomic DNA. Translation: AAB95333.1. Different termination.AF039459 AF039458 Genomic DNA. Translation: AAB95335.1.AF039460 AF039459 Genomic DNA. Translation: AAB95332.1.Y10296 mRNA. Translation: CAA71342.1. AF098792 Genomic DNA. Translation: AAD13218.1. |
| IPI | IPI00229997. IPI00229998. IPI00229999. IPI00230000. IPI00230203. |
| PIR | S68437. S68438. S68439. S68440. S68441. |
| RefSeq | NP_001116371.1. NM_001122899.1. NP_034834.1. NM_010704.2. NP_666258.2. NM_146146.2. |
| UniGene | Mm.259282. |
3D structure databases | |
| ProteinModelPortal | P48356. |
| SMR | P48356. Positions 220-323, 359-830. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-42763N. |
| IntAct | P48356. 3 interactions. |
| MINT | MINT-2569396. |
PTM databases | |
| PhosphoSite | P48356. |
Proteomic databases | |
| PaxDb | P48356. |
| PRIDE | P48356. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000037552; ENSMUSP00000037385; ENSMUSG00000057722. ENSMUST00000102777; ENSMUSP00000099838; ENSMUSG00000057722. ENSMUST00000106921; ENSMUSP00000102534; ENSMUSG00000057722. |
| GeneID | 16847. |
| KEGG | mmu:16847. |
| UCSC | uc008twa.1. mouse. |
Organism-specific databases | |
| CTD | 3953. |
| MGI | MGI:104993. Lepr. |
Phylogenomic databases | |
| eggNOG | NOG29456. |
| GeneTree | ENSGT00550000074436. |
| HOVERGEN | HBG000140. |
| InParanoid | P48356. |
| KO | K05062. |
| OMA | LKLFICY. |
| OrthoDB | EOG469QT5. |
Gene expression databases | |
| ArrayExpress | P48356. |
| Bgee | P48356. |
| CleanEx | MM_LEPR. |
| Genevestigator | P48356. |
| GermOnline | ENSMUSG00000057722. Mus musculus. |
Family and domain databases | |
| Gene3D | 2.60.40.10. 4 hits. |
| InterPro | IPR003961. Fibronectin_type3. IPR003529. Hematopoietin_rcpt_Gp130_CS. IPR003531. Hempt_rcpt_S_F1_CS. IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR010457. IgC2-like_lig-bd. IPR015752. Lep_receptor. [Graphical view] |
| PANTHER | PTHR23036:SF11. PTHR23036:SF11. 1 hit. |
| Pfam | PF06328. Lep_receptor_Ig. 1 hit. [Graphical view] |
| SMART | SM00060. FN3. 4 hits. [Graphical view] |
| SUPFAM | SSF49265. FN_III-like. 4 hits. |
| PROSITE | PS50853. FN3. 4 hits. PS01353. HEMATOPO_REC_L_F2. 1 hit. PS50835. IG_LIKE. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 290776. |
| SOURCE | Search... |
Entry information
| Entry name | LEPR_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P48356 Secondary accession number(s): O35686 Q9QWV5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
